These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12584851)

  • 1. [Pharmacokinetics of site-specific delivery of dexamethasone-dextran prodrug in rat gastrointestinal tract].
    Zhou SY; Mei QB; Zhou J; Liu L; Li C; Zhao DH
    Yao Xue Xue Bao; 2001 May; 36(5):325-8. PubMed ID: 12584851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on the enzyme dependant colon targeting prodrug--dexamethasone succinate dextran and its tablets].
    Pang YN; Zhang ZR; Pang QJ; Li TL
    Yao Xue Xue Bao; 2001 Aug; 36(8):625-30. PubMed ID: 12579944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of drug-release in vitro of different dextran-dexamethasone conjugates].
    Zhou SY; Mei QB; Liu L; Zhang BL; Li C; Zhou J
    Yao Xue Xue Bao; 2003 May; 38(5):388-91. PubMed ID: 12958847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone 21-sulfate improves the therapeutic properties of dexamethasone against experimental rat colitis by specifically delivering the steroid to the large intestine.
    Kim I; Kong H; Lee Y; Hong S; Han J; Jung S; Jung Y; Kim YM
    Pharm Res; 2009 Feb; 26(2):415-21. PubMed ID: 18958401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colon-specific delivery of dexamethasone from a glucoside prodrug in the guinea pig.
    Tozer TN; Rigod J; McLeod AD; Gungon R; Hoag MK; Friend DR
    Pharm Res; 1991 Apr; 8(4):445-54. PubMed ID: 1871038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of an enzyme-dependent prodrug and evaluation of its potential for colon targeting.
    Pang YN; Zhang Y; Zhang ZR
    World J Gastroenterol; 2002 Oct; 8(5):913-7. PubMed ID: 12378641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budesonide-beta-D-glucuronide: a potential prodrug for treatment of ulcerative colitis.
    Nolen H; Fedorak RN; Friend DR
    J Pharm Sci; 1995 Jun; 84(6):677-81. PubMed ID: 7562403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colonic delivery of dexamethasone from a prodrug accelerates healing of colitis in rats without adrenal suppression.
    Fedorak RN; Haeberlin B; Empey LR; Cui N; Nolen H; Jewell LD; Friend DR
    Gastroenterology; 1995 Jun; 108(6):1688-99. PubMed ID: 7768373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of glucocorticoid conjugate in rat gastrointestinal tract and its treatment for ulcerative colitis.
    Zhou SY; Mei QB; Liu L; Guo X; Qiu BS; Zhao DH; Cho CH
    Acta Pharmacol Sin; 2001 Aug; 22(8):761-4. PubMed ID: 11749853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents.
    McLeod AD; Friend DR; Tozer TN
    J Pharm Sci; 1994 Sep; 83(9):1284-8. PubMed ID: 7530303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo pharmacokinetic study for the assessment of poly(L-aspartic acid) as a drug carrier for colon-specific drug delivery.
    Leopold CS; Friend DR
    J Pharmacokinet Biopharm; 1995 Aug; 23(4):397-406. PubMed ID: 8882747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: steady-state pharmacokinetics in the rat.
    McLeod AD; Tolentino L; Tozer TN
    Biopharm Drug Dispos; 1994 Mar; 15(2):151-61. PubMed ID: 7516722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steady-state pharmacokinetics of corticosteroid delivery from glucuronide prodrugs in normal and colitic rats.
    Nolen HW; Fedorak RN; Friend DR
    Biopharm Drug Dispos; 1997 Nov; 18(8):681-95. PubMed ID: 9373725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugation of metronidazole with dextran: a potential pharmaceutical strategy to control colonic distribution of the anti-amebic drug susceptible to metabolism by colonic microbes.
    Kim W; Yang Y; Kim D; Jeong S; Yoo JW; Yoon JH; Jung Y
    Drug Des Devel Ther; 2017; 11():419-429. PubMed ID: 28243064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of dextran-flufenamic acid ester as a polymeric colon-specific prodrug of flufenamic acid, an anti-inflammatory drug, for chronotherapy.
    Lee Y; Kim IH; Kim J; Yoon JH; Shin YH; Jung Y; Kim YM
    J Drug Target; 2011 Jun; 19(5):336-43. PubMed ID: 20615092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of dexamethasone-beta-D-glucuronide for colon-specific drug delivery.
    Haeberlin B; Rubas W; Nolen HW; Friend DR
    Pharm Res; 1993 Nov; 10(11):1553-62. PubMed ID: 8290467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis.
    Varshosaz J; Emami J; Tavakoli N; Fassihi A; Minaiyan M; Ahmadi F; Dorkoosh F
    Int J Pharm; 2009 Jan; 365(1-2):69-76. PubMed ID: 18804521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: plasma and tissue disposition.
    Zhang X; Mehvar R
    J Pharm Sci; 2001 Dec; 90(12):2078-87. PubMed ID: 11745766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro properties of dexamethasone 21-sulfate sodium as a colon-specific prodrug of dexamethasone.
    Kim IH; Kong HS; Choi BI; Kim YS; Kim HJ; Yang YW; Jung YJ; Kim YM
    Drug Dev Ind Pharm; 2006 Mar; 32(3):389-97. PubMed ID: 16556543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoscale Lipophilic Prodrugs of Dexamethasone with Enhanced Pharmacokinetics.
    Lorscheider M; Tsapis N; Simón-Vázquez R; Guiblin N; Ghermani N; Reynaud F; Canioni R; Abreu S; Chaminade P; Fattal E
    Mol Pharm; 2019 Jul; 16(7):2999-3010. PubMed ID: 31117740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.